Regen BioPharma, Inc.
RGBP
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -637.80K | 991.90K | -967.90K | -572.50K | -167.30K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 8.80K | 8.70K | 8.90K | 34.20K | -7.40K |
| Total Other Non-Cash Items | 671.10K | -1.16M | 780.80K | 323.60K | 187.80K |
| Change in Net Operating Assets | -66.10K | 97.40K | -19.80K | 54.60K | -69.10K |
| Cash from Operations | -24.10K | -63.20K | -197.90K | -160.00K | -56.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 33.00K | -- | -- | 119.60K | 56.00K |
| Total Debt Repaid | -8.90K | 8.90K | -58.80K | -- | -- |
| Issuance of Common Stock | 0.00 | 50.00K | 191.80K | 58.20K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 50.00K | -- |
| Cash from Financing | 24.00K | 58.90K | 133.00K | 227.80K | 56.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00 | -4.30K | -65.00K | 67.80K | 0.00 |